Learn More
Invitrogen™ TAZ Polyclonal Antibody

Description
TAZ Polyclonal Antibody for Flow, IHC (P), Western Blot
Specifications
Specifications
| Antigen | TAZ |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | TAZ |
| Gene Accession No. | Q16635 |
| Gene Alias | 2310058J06Rik; 2610021I22Rik; 5031411C02Rik; 9130012G04Rik; AW107266; AW552613; Barth syndrome); BTHS; C78399; cardiomyopathy, dilated 3A (X-linked); CMD3A; EFE; EFE2; endocardial fibroelastosis 2; FLJ27390; G4.5; HGNC:11577; LVNCX; OTTHUMP00000061673; protein G4.5; Tafazzin; tafazzin (cardiomyopathy, dilated 3A (X-linked); tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome); Taz; Taz1; transcriptional coactivator with PDZ binding motif; transcriptional co-activator with PDZ-binding motif; transcriptional coactivator with PDZ-binding motif; transcriptional co-activator with PDZ-binding motif (TA)Z; transcriptional co-activator with PDZ-binding motif (TAZ); WW domain containing transcription regulator 1; WW domain-containing transcription regulator protein 1; Wwtr1; XAP-2; XX-FW83563B9.3 |
| Gene Symbols | TAZ |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.